Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
A series of experiments was performed to investigate the effects of corticotropin-releasing factor (CRF) on the amplitude of the acoustic startle response (ASR) in rats. Intracerebroventricular (ICV) administration of 1 microgram rat CRF significantly potentiated acoustic startle amplitude; these effects were reversed in a dose-dependent manner by pretreatment with the benzodiazepine chlordiazepoxide (CDP). Doses of CDP that antagonized CRF-potentiated ASR did not lower startle baseline or antagonize amphetamine- or strychnine-potentiated ASR. These results suggest that CRF has "anxiogenic" properties and may serve as a neuroendocrine modulator of stress-enhanced behaviors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“infusions of CRF into the lateral cerebral ventricle markedly increased the amplitude of the acoustic startle response in rats (CRF-enhanced startle).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
In the citing paper
“The benzodiazepine anxiolytic, chlordiazepozide, reduced this effect, but in control studies it did not reduce startle increases produced by the inhibitory glycine receptor antagonist strychnine”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
In the citing paper
“CRF-enhanced startle (Swerdlow et al, 1986)”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904 · cited 1×
“CRF is a 41 amino-acid polypeptide released within the median eminence from cells in the paraventricular nucleus of the hypothalamus, which stimulates the release of ACTH and/Lendorphin from the anterior pituitary (Rivier et al. 1981 ; Vale et al. 1981).”
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Self-citationA primary acoustic startle circuit: lesion and stimulation studies
Davis, M., Gendelman, D., Tischler, M., & Gendelman, P. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-06-00791.1982 · Cited by 969 · cited 1×
“acoustic startle is controlled by a well-characterized neural circuit (Davis et al. 1982), and thus permits an analysis of the neural substrates of anxiety (Mondlock and Davis 1985).”
Corticotropin releasing factor produces behavioural activation in rats
Sutton, R. E., Koob, G. F., Le Moal, M., Rivier, J., & Vale, W. (1982) · Nature · doi:10.1038/297331a0 · Cited by 754 · cited 3×
“1985), and are not produced by peripheral injections of CRF in doses greater by orders of magnitude (Sutton et al. 1982).”
InfluentialSelf-citationConditioned fear as revealed by magnitude of startle response to an auditory stimulus.
Brown, J. S., Kalish, H. I., & Farber, I. E. (1951) · Journal of Experimental Psychology · doi:10.1037/h0060166 · Cited by 637 · cited 1×
“In rats, the ASR has been shown to be sensitive to states of stress or fear, since ASR amplitude is enhanced by drugs (such as piperoxane and yohimbine) that have anxiogenic properties in humans (Davis and Astrachan 1981) and when the acoustic stimulus is presented during another stimulus (light, for example) that has…”
Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus
Valentino, R. J., Foote, S. L., & Aston-Jones, G. (1983) · Brain Research · doi:10.1016/0006-8993(83)90615-7 · Cited by 603 · cited 1×
“1983), and CRF has been shown to increase firing frequencies of cells within the locus coeruleus in vivo (Valentino et al. 1983), and to activate cells in hippocampal slice preparations (Aldenhoff et al.”
RIVIER, C., BROWNSTEIN, M., SPIESS, J., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555
Self-citationHitchcock, J., & Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.1.11 · Cited by 541 · cited 1×
“1982), and thus permits an analysis of the neural substrates of anxiety (Mondlock and Davis 1985).”
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534 · cited 1×
“Koob stricted to the outer walls of the environment, together with decreased exploration and increased grooming (Britton et al. 1982).”
Self-citation
Research works printed but not linked: 2
- Britton T, Lyon M, Vale W, Koob G (1984) Stress-induced secretion of corticotropin releasing factor immunoreactivity in rat cerebrospinal fluid. Soc Neurosci Abstr 10:94
- Weiss S, Post R, Gold P, Chrousos G, Sullivan T, Walker D, Pert A (1984) CRF-induced aggressive behavior and seizures: facilitation of amygdala kindling. Soc Neurosci Abstr 10:178
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Caldji, C., Tannenbaum, B., Sharma, S., Francis, D., Plotsky, P. M., & Meaney, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5335 · Cited by 1,437
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Fear and anxiety: Animal models and human cognitive psychophysiology
Lang, P. J., Davis, M., & Öhman, A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00343-8 · Cited by 1,162
Clinical and Biochemical Manifestations of Depression
Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190706 · Cited by 1,053
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838
DEMITRACK, M. A., DALE, J. K., STRAUS, S. E., LAUE, L., LISTWAK, S. J., KRUESI, M. J. P., CHROUSOS, G. P., & GOLD, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1224 · Cited by 727
Corticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629
Self-citationNeural systems involved in fear and anxiety measured with fear-potentiated startle.
Davis, M. (2006) · American Psychologist · doi:10.1037/0003-066x.61.8.741 · Cited by 592
Caldji, C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00110-4 · Cited by 606
Variations in maternal care in infancy regulate the development of stress reactivity
Caldji, C., Diorio, J., & Meaney, M. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01084-2 · Cited by 574
Are different parts of the extended amygdala involved in fear versus anxiety?
Davis, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00288-1 · Cited by 549
A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
Koob, G. F., & Heinrichs, S. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01991-5 · Cited by 531
Self-citationPlotsky, P. M., Thrivikraman, K. V., Nemeroff, C. B., Caldji, C., Sharma, S., & Meaney, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300769 · Cited by 522
“…freezing (Sherman and Kalin, 1988) and grooming (Britton et al, 1984; Imaki et al, 1987), decreased sexual behavior (Sirinathsinghji et al, 1983), facilitation of acoustic startle (Swerdlow et al, 1986; Liang et al, 1992a, b), and decreased food intake (Krahn et al, 1986; Arase et al, 1988).”
BackgroundStartle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology
Grillon, C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01665-7 · Cited by 494
“In addition, intraventricular administration of CRH produces a longlasting potentiation of the startle reflex (Liang et al 1992; Swerdlow et al 1986), which is suppressed by the anxiolytic benzodiazepine chlordiazepoxide (Swerdlow et al 1986).”
BackgroundRole of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationD 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist Effects
Walters, J. R., Bergstrom, D. A., Carlson, J. H., Chase, T. N., & Braun, A. R. (1987) · Science · doi:10.1126/science.2953072 · Cited by 465
Differences in fear motivated behaviors among inbred mouse strains
Trullas, R., & Skolnick, P. (1993) · Psychopharmacology · doi:10.1007/bf02244948 · Cited by 451
Models and mechanisms of anxiety: evidence from startle studies
Grillon, C. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1019-1 · Cited by 456
“Infusion of CRH into the lateral ventricle produces a dose-dependent facilitation of startle lasting up to several hours (Risbrough et al. 2003; Swerdlow et al. 1986), which can be blocked by anxiolytic drugs (Swerdlow et al. 1986).”
BackgroundKelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart-Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03470.1998 · Cited by 447
Butler, P., Weiss, J., Stout, J., & Nemeroff, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00176.1990 · Cited by 402
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351
Allostasis, amygdala, and anticipatory angst
Schulkin, J., McEwen, B. S., & Gold, P. W. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90051-5 · Cited by 380
Lee, Y., López, D. E., Meloni, E. G., & Davis, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-11-03775.1996 · Cited by 381
Schulz, D. W., Mansbach, R. S., Sprouse, J., Braselton, J. P., Collins, J., Corman, M., Dunaiskis, A., Faraci, S., Schmidt, A. W., Seeger, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10477 · Cited by 377
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
The human BNST: functional role in anxiety and addiction
Avery, S. N., Clauss, J. A., & Blackford, J. U. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.185 · Cited by 331
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
“CRF-Enhanced versus Fear-Potentiated Startle In 1986, Swerdlow et al. (1986) reported that CRF infusions into the lateral cerebral ventricle markedly increased startle amplitude in rats, and that these increases were prevented by pretreatment with the anxiolytic compound chlordiazepoxide.”
BackgroundDAVIS, M., & SHI, C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09273.x · Cited by 328
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
Self-citationStress & sleep: A relationship lasting a lifetime
Lo Martire, V., Caruso, D., Palagini, L., Zoccoli, G., & Bastianini, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.024 · Cited by 290
Rainnie, D. G., Bergeron, R., Sajdyk, T. J., Patil, M., Gehlert, D. R., & Shekhar, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5740-03.2004 · Cited by 293
DAVIS, M., WALKER, D. L., & LEE, Y. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48289.x · Cited by 281
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
“Central administration of CRF mimics the behavioral responses to stress in rodents (Britton et al 1985; Dunn and File 1987; Sutton et al 1982; Swerdlow et al 1986), while administration of CRF antagonists reverses these effects (Britton et al 1986; Swerdlow et al 1989; Zorrilla et al 2002).”
BackgroundSelf-citationThe Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
Grillon, C., Morgan, C. A., Davis, M., & Southwick, S. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00034-1 · Cited by 263
Sternberg, E. M., Glowa, J. R., Smith, M. A., Cologero, A. E., Listwak, S. J., Aksentijevich, S., Chrousos, G. P., Wilder, R. L., & Gold, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90563-o · Cited by 260
The American Association for Research into Nervous and Mental Diseases, Davis, M., Walker, D. L., & Lee, Y. (1997) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1997.0149 · Cited by 254
Role of corticotropin releasing factor in anxiety disorders: A translational research perspective
Risbrough, V. B., & Stein, M. B. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.019 · Cited by 236
“…fear-potentiated startle; FPS) or administration of anxiogenic compounds, such as CRF, increases startle (Brown et al., 1951;Davis et al., 1997;Swerdlow et al., 1986), while threat-reducing stimuli (Lang et al., 1990), anxiolytic and sedative drugs (Abduljawad et al., 2001) or sensory input…”
BackgroundCorticotropin-releasing factor has an anxiogenic action in the social interaction test
DUNN, A. (1987) · Hormones and Behavior · doi:10.1016/0018-506x(87)90044-4 · Cited by 242
Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety
Shekhar, A., Truitt, W., Rainnie, D., & Sajdyk, T. (2005) · Stress · doi:10.1080/10253890500504557 · Cited by 237
“CRF injections into the cerebral ventricles induce anxiety-like responses in several animal tests of anxiety, such as the conflict test (Britton et al. 1986), social interaction test (Dunn and File 1987), acoustic startle (Swerdlow et al. 1986) and elevated plus maze (File et al. 1988).”
MethodSwerdlow, N. R., Mansbach, R. S., Geyer, M. A., Pulvirenti, L., Koob, G. F., & Braff, D. L. (1990) · Psychopharmacology · doi:10.1007/bf02244616 · Cited by 235
Self-citationStress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
Self-citationThe Role of Corticotropin‐Releasing Factor in Behavioural Responses to Stress
Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H., Miczek, K., & Britton, K. T. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514368.ch14 · Cited by 232
Self-citationSensitization of the acoustic startle reflex by footshock.
Davis, M. (1989) · Behavioral Neuroscience · doi:10.1037//0735-7044.103.3.495 · Cited by 229
DEMITRACK, M. A., & CROFFORD, L. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09607.x · Cited by 221
The neuroendocrinology of chronic fatigue syndrome and fibromyalgia
PARKER, A. J. R., WESSELY, S., & CLEARE, A. J. (2001) · Psychological Medicine · doi:10.1017/s0033291701004664 · Cited by 206
Cratty, M. S., Ward, H. E., Johnson, E. A., Azzaro, A. J., & Birkle, D. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00087-7 · Cited by 201
Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex
Liang, K., Melia, K., Miserendino, M., Falls, W., Campeau, S., & Davis, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-06-02303.1992 · Cited by 203
GOLD, P. W., LICINIO, J., WONG, M., & CHROUSOS, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44723.x · Cited by 199
Morgan, C. A., Wang, S., Rasmusson, A., Hazlett, G., Anderson, G., & Charney, D. S. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00010 · Cited by 188
Sajdyk, T. J., Schober, D. A., Gehlert, D. R., & Shekhar, A. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00132-6 · Cited by 191
Kosten, T. A., & Ambrosio, E. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00035-x · Cited by 188
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E. P., & Koob, G. F. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 176
Self-citationIs There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?
Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171
Calogero, A. E., Gallucci, W. T., Chrousos, G. P., & Gold, P. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90523-9 · Cited by 166
Liang, K. C., & Lee, E. Y. (1988) · Psychopharmacology · doi:10.1007/bf00177566 · Cited by 171
“This "non-monotonic" dose-response function of CRF in modulating memory or activities is similar to that demonstrated in the effects of CRF or footshock stress in modulating the startle response (Davis and Astrachan 1978; Swerdlow et al. 1986).”
ResultIncreased pituitary activation following metyrapone administration in post-traumatic stress disorder
Yehuda, R., Levengood, R. A., Schmeidler, J., Wilson, S., Song Guo, L., & Gerber, D. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00055-0 · Cited by 166
Sanford, L. D., Suchecki, D., & Meerlo, P. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_314 · Cited by 178
“…administration of CRH in rats produces many of the signs associated with anxiety in humans, including increased wakefulness (Ehlers et al. 1986; Marrosu et al. 1990; Chang and Opp 1998), altered locomotor activity, and an exaggerated startle response (Swerdlow et al. 1986; Heilig et al. 1994).”
Arnold, F. J. L., de Lucas Bueno, M., Shiers, H., Hancock, D. C., Evan, G. I., & Herbert, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90322-s · Cited by 155
PSYCHONEUROENDOCRINOLOGY OF POST-TRAUMATIC STRESS DISORDER
Yehuda, R. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70010-1 · Cited by 172
The effect of gonadal hormones and gender on anxiety and emotional learning
Toufexis, D. J., Myers, K. M., & Davis, M. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.020 · Cited by 162
Valdez, G. R., & Koob, G. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.020 · Cited by 157
Self-citationKling, M. A., Roy, A., Doran, R. J., Calabrese, J. R., Rubinow, D. R., DAVID, H. J., May, C., Post, R. M., Chrousos, G. P., & Gold, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-260 · Cited by 145
Britton, K. T., Lee, G., Dana, R. C., Risch, S. C., & Koob, G. F. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90189-x · Cited by 144
Self-citationValdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 158
Self-citationEndogenous opioids: The downside of opposing stress
Valentino, R. J., & Van Bockstaele, E. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.09.006 · Cited by 133
A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety
Pomrenze, M. B., Tovar-Diaz, J., Blasio, A., Maiya, R., Giovanetti, S. M., Lei, K., Morikawa, H., Hopf, F. W., & Messing, R. O. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2143-18.2018 · Cited by 140
“In agreement with this hypothesis, CRF administration into the ventricles or the dorsolateral BST (dlBST) in rats generates anxiety-like behaviors (Swerdlow et al., 1986; Liang et al., 1992; Lee and Davis, 1997; Sahuque et al., 2006) that are reduced by CRF 1 receptor antagonists injected into the…”
MethodThe Amygdala, Panic Disorder, and Cardiovascular Responses
Shekhar, A., Sajdyk, T. J., Gehlert, D. R., & Rainnie, D. G. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07090.x · Cited by 152
Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats
Takahashi, T., Morinobu, S., Iwamoto, Y., & Yamawaki, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0545-6 · Cited by 138
“Since the administration of CRH has been shown to potentiate acoustic startle response in rats ( Swerdlow et al. 1986 ), it may have “anxiogenic” properties.”
BackgroundMoberg, C. A., & Curtin, J. J. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0015636 · Cited by 138
“For example, corticotropin-releasing factor (CRF; a stress hormone) has been observed to potentiate startle when administered to rats (Swerdlow et al., 1986; Liang et al., 1992).”
Neural Systems Involved in Fear‐Potentiated Startle
DAVIS, M. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb42197.x · Cited by 133
Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 140
Keen‐Rhinehart, E., Michopoulos, V., Toufexis, D. J., Martin, E. I., Nair, H. P., Ressler, K. J., Davis, M., Owens, M. J., Nemeroff, C. B., & Wilson, M. E. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.91 · Cited by 134
Molecular and genetic substrates linking stress and addiction
Briand, L. A., & Blendy, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.002 · Cited by 125
“CRF administration enhances stress related behaviors such as acoustic startle, conditioned fear and stress-induced freezing behavior (Cole and Koob, 1988; Swerdlow et al., 1986).”
BackgroundFrom Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
Risbrough, V. B., Hauger, R. L., Roberts, A. L., Vale, W., & Geyer, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5760-03.2004 · Cited by 134
Self-citationCrofford, L. J., & Demitrack, M. A. (1996) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70272-6 · Cited by 138
Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats
Kalin, N. H., Sherman, J. E., & Takahashi, L. K. (1988) · Brain Research · doi:10.1016/0006-8993(88)90064-9 · Cited by 122
Walker, D., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1213-0 · Cited by 122
“This effect is blocked by the chlordiazepoxide and by other benzodiazepine ligands with anxiolytic activity (Swerdlow and Britton 1994; Swerdlow et al. 1986).”
BackgroundSkelton, K. H., Nemeroff, C. B., Knight, D. L., & Owens, M. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01240.2000 · Cited by 127
Stress and the Neuroendocrinology of Anxiety Disorders
Pêgo, J. M., Sousa, J. C., Almeida, O., & Sousa, N. (2009) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_13 · Cited by 106
Martin, E. R., Menold, M. M., Wolpert, C. M., Bass, M. P., Donnelly, S. L., Ravan, S. A., Zimmerman, A., Gilbert, J. R., Vance, J. M., Maddox, L. O., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1<43::aid-ajmg9>3.0.co;2-3 · Cited by 161
Gehlert, D. R., Shekhar, A., Morin, S. M., Hipskind, P. A., Zink, C., Gackenheimer, S. L., Shaw, J., Fitz, S. D., & Sajdyk, T. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.030 · Cited by 123
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 112
“It has been hypothesized that this effect reflects increased fear or anxiety since an anxiolytic, chlordiazepoxide, also blocks this effect, without blocking a similar effect produced by d-amphetamine or strychnine (180).”
BackgroundHe, L., Gilligan, P. J., Zaczek, R. C., Fitzgerald, L. W., McElroy, J., Shen, H.-S. L., Saye, J. A., Kalin, N. H., Shelton, S. E., Christ, D. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904351 · Cited by 117
Meloni, E. G., Gerety, L. P., Knoll, A. T., Cohen, B. M., & Carlezon, W. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4957-05.2006 · Cited by 109
“CRF-enhanced startle is blocked by CRF antagonists (Schulz et al., 1996) and by drugs that modulate GABAergic systems such as the anxiolytic drug chlordiazepoxide (Swerdlow et al., 1986) or the neurosteroid tetrahydroprogesterone (Toufexis et al., 2004).”
Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety
Thorsell, A. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009331 · Cited by 115
Risbrough, V. B., Hauger, R. L., Pelleymounter, M. A., & Geyer, M. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1535-6 · Cited by 114
“As CRF effects on ASR in mice had not yet been tested, we first examined if the increases in ASR induced by central administration of human/rat (h/r)-CRF to rats (Swerdlow et al. 1986) would also be demonstrable in two common inbred strains of mice.”
BackgroundInfluentialSelf-citationIrwin, M. R. (1994) · Advances in Neuroimmunology · doi:10.1016/s0960-5428(06)80188-9 · Cited by 109
Recent developments in anxiety, stress, and depression
File, S. E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02175-2 · Cited by 118
Dysregulation of the Hypothalamic-Pituitary-Adrenocortical System in Panic Disorder
Schreiber, W., Lauer, C. J., Krumrey, K., Holsboer, F., & Krieg, J. C. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00146-5 · Cited by 123
Asok, A., Draper, A., Hoffman, A. F., Schulkin, J. A., Lupica, C. R., & Rosen, J. B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.79 · Cited by 106
Lee, Y., Schulkin, J. A., & Davis, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90286-0 · Cited by 114
Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats
Ehlers, C. L., Chaplin, R. I., Wall, T. L., Lumeng, L., Li, T., Owens, M. J., & Nemeroff, C. B. (1992) · Psychopharmacology · doi:10.1007/bf02245418 · Cited by 100
El-Kabir, D. R., Wyatt, M. E., Vellucci, S. V., & Herbert, J. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90018-r · Cited by 104
Sink, K. S., Walker, D. L., Yang, Y., & Davis, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5274-10.2011 · Cited by 99
“Many of the terminals of these parabrachial neurons form perisomatic baskets around BNST cells that express corticotropinreleasing factor (CRF) (Kozicz and Arimura, 2001)—another peptide well known for its involvement in stress and anxiety (Swerdlow et al., 1986; Hauger et al., 2009).”
BackgroundHerbert, J. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90033-o · Cited by 98
Charney, D. S., Grillon, C., & Bremner, J. D. (1998) · The Neuroscientist · doi:10.1177/107385849800400208 · Cited by 100
Metadata
- Authors
- Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F.
- Affiliations
- University of California San Diego (US)
- Salk Institute for Biological Studies (US)
- Scripps Clinic (US)
- Venue
- Psychopharmacology
- Published
- 1986
- Volume
- 88
- Issue
- 2
- Pages
- 147-152
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2010001782
- Cited by
- 299
- References
- 34
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 4
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2p01am026741-06)
- National Institute of General Medical Sciences (GM 07198-10)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- corticotropin-releasing factor, acoustic startle response, chlordiazepoxide, benzodiazepines, anxiogenic effects, stress, neuroendocrine regulation, intracerebroventricular administration
- MeSH terms
- Acoustic Stimulation, Animals, Anxiety, Chlordiazepoxide, Corticotropin-Releasing Hormone, Dextroamphetamine, Drug Interactions, Male, Rats, Inbred Strains, Reflex, Startle, Strychnine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.